Results 161 to 170 of about 708,008 (375)
OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.
Raveendhara R. Bannuru +22 more
semanticscholar +1 more source
Pharmaceutical Treatment of Osteoarthritis.
M. J. Richard, J. Driban, T. McAlindon
semanticscholar +1 more source
LSMEM1, an evolutionarily conserved micropeptide with extreme hydrophobicity (aliphatic index═113) and dynamic amphiphilicity (GRAVY═0.017), features a strong α‐helical transmembrane anchor (residues 64‐86). Single‐cell analysis reveals its critical role in renal lipid homeostasis.
Peimin Liu +11 more
wiley +1 more source
A novel bimetallic nanozyme (Fe2–NCs) with well‐defined Fe–Fe active sites is synthesized through a host–guest coordination strategy, which exhibits an exceptional therapeutic efficacy in osteoarthritis therapy. Experimental and theoretical analyses uncover the intrinsic catalytic mechanism at the atomic level, offering fundamental insights and design ...
Ting Ying +6 more
wiley +1 more source
Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health [PDF]
Usman Ahmed +12 more
openalex +1 more source
Exhausting circ_0136474 and Restoring miR-766-3p Attenuate Chondrocyte Oxidative Injury in IL-1β-Induced Osteoarthritis Progression Through Regulating DNMT3A [PDF]
Haiquan Zhu +6 more
openalex +1 more source
Epidemiology of Osteoarthritis.
Kelli D. Allen, L. Thoma, Y. Golightly
semanticscholar +1 more source
This study identifies CD74⁺ macrophages as key drivers of synovial inflammation in osteoarthritis (OA). The flavonoid luteolin is predicted to inhibit this pathway by blocking Nuclear Factor Kappa‐light‐chain‐enhancer of Activated B cells (NF‐κB) signaling. To enhance delivery, a targeted nanoplatform (MDSPL) is developed.
Rui Peng +15 more
wiley +1 more source

